Please login to the form below

Not currently logged in
Email:
Password:

prevention

This page shows the latest prevention news and features for those working in and with pharma, biotech and healthcare.

J&J’s Invokana first SGLT2 to show kidney disease benefits

J&J’s Invokana first SGLT2 to show kidney disease benefits

Could help revival after amputation risk scare

Latest news

  • Teva’s migraine injection approved in Europe Teva’s migraine injection approved in Europe

    Third anti-CGRP treatment to hit the market. The European Medicines Agency has approved Teva’s migraine prevention drug Ajovy, adding a third competitor to a fast-expanding market. ... for migraine prevention, gaining European approval in August last

  • Biogen and Eisai pull plug on Alzheimer’s drug Biogen and Eisai pull plug on Alzheimer’s drug

    Biogen says the decision around whether or not to start a planned phase 3 secondary prevention trial of aducanumab will also be reviewed while the data from ENGAGE and EMERGE are

  • Depression drug failure adds to Allergan's woes Depression drug failure adds to Allergan's woes

    Allergan says an interim analysis of rapastinel as a relapse prevention therapy (RAP-MD-04) suggests the primary and key secondary endpoints will not be met in this study either.

  • Going digital Going digital

    Innovations include the digitalisation of diagnosis and prevention through the use of wireless, mHealth solutions such as smartphone apps, wearables, gamification and remote monitoring.

  • Teva will have to endure revenue 'trough' in 2019 Teva will have to endure revenue 'trough' in 2019

    To reverse the trend, Teva needs new products such as migraine prevention therapy Ajovy (fremanezumab) and Austedo (deutetrabenazine) for tardive dyskinesia and chorea associated with Huntington’s disease to ramp up

More from news
Approximately 4 fully matching, plus 704 partially matching documents found.

Latest Intelligence

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimer’s drug discovery

    resources. One of the most notable is the European Prevention of Alzheimer’s Dementia (EPAD) project, an interdisciplinary research consortium that aims to improve understanding of the early stages of

  • Rare Diseases Day Rare Diseases Day

    or tablet, will allow people to find out more about research in the NHS, and consent to their health and care data being used for research into improving rare disease prevention, ... It has also committed to work to improve the prevention, detection and

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    The company maintains that Takhzyro has the potential to expand the HAE prevention market, particularly in international markets, as it is easier to administer than other drugs. ... It’s given as a subcutaneous injection that takes less than a minute

  • Leicester NHS Trust’s staff intranet is integral to HCPs’ working day

    The clinical section contains everything a doctor, nurse or other HCP might need, including clinical guidelines, training and education programmes, infection prevention policies and general hospital policies. ... Clinical education is another well-used

  • Deal Watch October 2018

    the prevention and treatment of parasite and other infections, could provide 6‐7B for enhancing the pharma portfolio.

More from intelligence
Approximately 2 fully matching, plus 76 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 41 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics